BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 14657853)

  • 1. IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses.
    Habib T; Nelson A; Kaushansky K
    J Allergy Clin Immunol; 2003 Dec; 112(6):1033-45. PubMed ID: 14657853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for IL-21 in regulating immunoglobulin production.
    Ozaki K; Spolski R; Feng CG; Qi CF; Cheng J; Sher A; Morse HC; Liu C; Schwartzberg PL; Leonard WJ
    Science; 2002 Nov; 298(5598):1630-4. PubMed ID: 12446913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of IL-21 and the IL-21 receptor.
    Mehta DS; Wurster AL; Grusby MJ
    Immunol Rev; 2004 Dec; 202():84-95. PubMed ID: 15546387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.
    Parrish-Novak J; Foster DC; Holly RD; Clegg CH
    J Leukoc Biol; 2002 Nov; 72(5):856-63. PubMed ID: 12429707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 signaling: functions in cancer and autoimmunity.
    Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
    Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.
    Strengell M; Julkunen I; Matikainen S
    J Leukoc Biol; 2004 Aug; 76(2):416-22. PubMed ID: 15178704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune modulation with interleukin-21.
    Bhave NS; Carson WE
    Ann N Y Acad Sci; 2009 Dec; 1182():39-46. PubMed ID: 20074273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen.
    Yan S; Marguet D; Dobers J; Reutter W; Fan H
    Eur J Immunol; 2003 Jun; 33(6):1519-27. PubMed ID: 12778469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
    Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
    J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21: an interleukin-2 dependent player in rejection processes.
    Baan CC; Balk AH; Dijke IE; Korevaar SS; Peeters AM; de Kuiper RP; Klepper M; Zondervan PE; Maat LA; Weimar W
    Transplantation; 2007 Jun; 83(11):1485-92. PubMed ID: 17565322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-21: a new modulator of immunity, infection, and cancer.
    Brandt K; Singh PB; Bulfone-Paus S; Rückert R
    Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21: roles in immunopathology and cancer therapy.
    Søndergaard H; Skak K
    Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WSX-1 over-expression in CD4(+) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation.
    Takeda A; Hamano S; Shiraishi H; Yoshimura T; Ogata H; Ishii K; Ishibashi T; Yoshimura A; Yoshida H
    Int Immunol; 2005 Jul; 17(7):889-97. PubMed ID: 15908443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade.
    Ostiguy V; Allard EL; Marquis M; Leignadier J; Labrecque N
    J Leukoc Biol; 2007 Sep; 82(3):645-56. PubMed ID: 17554014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked SCID and other defects of cytokine pathways.
    Uribe L; Weinberg KI
    Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.